Cleared Traditional

K932688 - EYE SPOT IM TEST

K932688 is an FDA 510(k) clearance for EYE SPOT IM TEST, manufactured by J.S. Medical Assoc.. The device is a Class 2 Immunology device with product code KTN cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K932688 · J.S. Medical Assoc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1993
Decision
97d
Days
Class 2
Risk

K932688 is an FDA 510(k) clearance for the EYE SPOT IM TEST. Classified as System, Test, Infectious Mononucleosis (product code KTN), Class II - Special Controls.

Submitted by J.S. Medical Assoc. (Natick, US). The FDA issued a Cleared decision on September 8, 1993 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5640 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all J.S. Medical Assoc. devices

FDA 510(k) Submission Details - K932688

510(k) Number K932688 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 1993
Decision Date September 08, 1993
Days to Decision 97 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 105d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KTN Device Classification - Class 2, Special Controls

Product Code KTN System, Test, Infectious Mononucleosis
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - KTN System, Test, Infectious Mononucleosis

All 42
Devices cleared under the same product code (KTN) and FDA review panel - the closest regulatory comparables to K932688.
BIOSIGN MONO-PLUS WB,BIOSIGN MONO WB,MONO-PLUS WB,ACCUSIGN MONO WB
K961024 · Princeton BioMeditech Corp. · Feb 1997
QUALITROL MONO CONTROL SERUM SET
K961550 · Consolidated Technologies, Inc. · Sep 1996
IMMUNOCARD MONO
K930778 · Meridian Diagnostics, Inc. · Dec 1993
ACCUTEX IM LATEX TEST
K932551 · J.S. Medical Assoc. · Aug 1993
ACCUTEX IM RBC TEST
K924037 · J.S. Medical Assoc. · Nov 1992
CARDS O.S. MONO
K902510 · Pacific Biotech, Inc. · Jul 1990